Sidaction Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2009
NCT00970879
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

mefloquine (lariam) (1 trial)

sulfamethoxazole (gantanol) (1 trial)

trimethoprim (1 trial)

Drugs in Phase 2 Trials (1)

rosuvastatin (crestor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 2)

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4